Food and Agricultural Organization. Food balance sheets. [http://www.fao.org/]
Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M: Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009, 169 (22): 2053-2063. 10.1001/archinternmed.2009.439.
Sääksjärvi K, Knekt P, Rissanen H, Laaksonen MA, Reunanen A, Männistö S: Prospective study of coffee consumption and risk of Parkinson's disease. Eur J Clin Nutr. 2008, 62 (7): 908-915.
Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ, Hoofnagle JH: Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology. 2010, 51 (1): 201-209.
World Cancer Research Fund/American Institute for Cancer Research. 2007, Food, Nutrition, Physical Activity and the Prevenvion of Cancer: A Global Perspective, American Institute for Cancer Research, Washington, DC
Huber WW, Scharf G, Nagel G, Prustomersky S, Schulte-Hermann R, Kaina B: Coffee and its chemopreventive components Kahweol and Cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver-comparison with phase II xenobiotic metabolism. Mutat Res. 2003, 522: 57-68. 10.1016/S0027-5107(02)00264-6.
Cavin C, Marin-Kuan M, Langouët S, Bezençon C, Guignard G, Verguet C, Piguet D, Holzhäuser D, Cornaz R, Schilter B: Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver. Food Chem Toxicol. 2008, 46 (4): 1239-1248. 10.1016/j.fct.2007.09.099.
Ramos S: Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res. 2008, 52: 507-526. 10.1002/mnfr.200700326.
Vucic EA, Brown CJ, Lam WL: Epigenetics of cancer progression. Pharmacogenomics. 2008, 9: 215-234. 10.2217/14622418.104.22.168.
Shearer J, Farah A, de Paulis T, Bracy DP, Pencek RR, Graham TE, Wasserman DH: Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr. 2003, 133 (11): 3529-3532.
Renehan AG, Roberts DL, Dive C: Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008, 114: 71-83. 10.1080/13813450801954303.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283: 2008-2012.
Greenland S, Longnecker MP: Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992, 135: 1301-1309.
Orsini N, Bellocco R, Greenland S: Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006, 6: 40-57.
Inoue M, Yoshimi I, Sobue T, Tsugane S, JPHC Study Group: Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst. 2005, 97 (4): 293-300. 10.1093/jnci/dji040.
Shimazu T, Tsubono Y, Kuriyama S, Ohmori K, Koizumi Y, Nishino Y, Shibuya D, Tsuji I: Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer. 2005, 116 (1): 150-154. 10.1002/ijc.20989.
Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H, Sakata R, Fujita Y, Ichikawa S, Iwai N, Tamakoshi A, JACC Study Group: Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer. 2005, 93 (5): 607-610. 10.1038/sj.bjc.6602737.
Hu G, Tuomilehto J, Pukkala E, Hakulinen T, Antikainen R, Vartiainen E, Jousilahti P: Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology. 2008, 48 (1): 129-136. 10.1002/hep.22320.
Shimazu T, Inoue M, Sasazuki S, Iwasaki M, Kurahashi N, Yamaji T, Tsugane S, JPHC Study Group Members of the Japan Public Health Center-based Prospective Study: Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer. 2008, 123 (10): 2406-2410. 10.1002/ijc.23760.
Friberg E, Orsini N, Mantzoros CS, Wolk A: Coffee drinking and risk of endometrial cancer-A population-based cohort study. Int J Cancer. 2009, 125: 2413-2417. 10.1002/ijc.24543.
Larsson SC, Wolk A: Coffee consumption is not associated with ovarian cancer incidence. Cancer Epidemiol Biomarkers Prev. 2005, 14 (9): 2273-2274. 10.1158/1055-9965.EPI-05-0280.
Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE: Intake of coffee and tea and risk of ovarian cancer: a prospective cohort study. Nutr Cancer. 2007, 58 (1): 22-27.
Steevens J, Schouten LJ, Verhage BA, Goldbohm RA, van den Brandt PA: Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer. 2007, 97 (9): 1291-1294. 10.1038/sj.bjc.6604008.
Tworoger SS, Gertig DM, Gates MA, Hecht JL, Hankinson SE: Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer. 2008, 112 (5): 1169-1177. 10.1002/cncr.23275.
van Loon AJ, Goldbohm RA, van den Brandt PA: Socioeconomic status and stomach cancer incidence in men: results from The Netherlands Cohort Study. Epidemiol Community Health. 1998, 52: 166-171. 10.1136/jech.52.3.166.
Galanis DJ, Kolonel LN, Lee J, Nomura A: Intakes of selected foods and beverages and the incidence of gastric cancer among the Japanese residents of Hawaii: a prospective study. International Journal of Epidemiology. 1998, 27: 173-180. 10.1093/ije/27.2.173.
Tsubono Y, Nishino Y, Komatsu S, Hsieh CC, Kanemura S, Tsuji I, Nakatsuka H, Fukao A, Satoh H, Hisamichi S: Green tea and the risk of gastric cancer in Japan. N Engl J Med. 2001, 344 (9): 632-636. 10.1056/NEJM200103013440903.
Larsson SC, Giovannucci E, Wolk A: Coffee consumption and stomach cancer risk in a cohort of Swedish women. Int J Cancer. 2006, 119 (9): 2186-2189. 10.1002/ijc.22105.
Wu AH, Paganini-Hill A, Ross RK, Henderson BE: Alcohol, physical activity and other risk factors for colorectal cancer: A prospective study. Br J Cancer. 1987, 55: 687-694. 10.1038/bjc.1987.140.
Klatsky AL, Armstrong MA, Friedman GD, Hiatt RA: The relations of alcoholic beverage use to colon and rectal cancer. Am J Epidemiol. 1988, 128 (5): 1007-1015.
Hartman TJ, Tangrea JA, Pietinen P, Malila N, Virtanen M, Taylor PR, Albanes D: Tea and coffee consumption and risk of colon and rectal cancer in middle-aged Finnish men. Nutr Cancer. 1998, 31 (1): 41-48. 10.1080/01635589809514676.
Terry P, Bergkvist L, Holmberg L, Wolk A: Coffee consumption and risk of colorectal cancer in a population based prospective cohort of Swedish women. Gut. 2001, 49 (1): 87-90. 10.1136/gut.49.1.87.
Michels KB, Willett WC, Fuchs CS, Giovannucci E: Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. Natl Cancer Inst. 2005, 97 (4): 282-292. 10.1093/jnci/dji039.
Larsson SC, Bergkvist L, Giovannucci E, Wolk A: Coffee consumption and incidence of colorectal cancer in two prospective cohort studies of Swedish women and men. Am J Epidemiol. 2006, 163 (7): 638-644. 10.1093/aje/kwj067.
Oba S, Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T, Matsushita S: The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: a prospective study in Japan. Cancer Lett. 2006, 244 (2): 260-267. 10.1016/j.canlet.2005.12.037.
Naganuma T, Kuriyama S, Akhter M, Kakizaki M, Nakaya N, Matsuda-Ohmori K, Shimazu T, Fukao A, Tsuji I: Coffee consumption and the risk of colorectal cancer: a prospective cohort study in Japan. Int J Cancer. 2007, 120 (7): 1542-1547. 10.1002/ijc.22505.
Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S, JPHC Study Group: Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. Int J Cancer. 2007, 121 (6): 1312-1318. 10.1002/ijc.22778.
Peterson S, Yuan JM, Koh WP, Sun CL, Wang R, Turesky RJ, Yu MC: Coffee intake and risk of colorectal cancer among Chinese in Singapore: the Singapore Chinese Health Study. Nutr Cancer. 2010, 62 (1): 21-29. 10.1080/01635580903191528.
Høyer AP, Engholm G: Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women. Cancer Causes Control. 1992, 3 (5): 403-408.
Key TJ, Sharp GB, Appleby PN, Beral V, Goodman MT, Soda M, Mabuchi K: Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer. 1999, 81 (7): 1248-1256. 10.1038/sj.bjc.6690837.
Michels KB, Holmberg L, Bergkvist L, Wolk A: Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women. Ann Epidemiol. 2002, 12 (1): 21-26. 10.1016/S1047-2797(01)00238-1.
Suzuki Y, Tsubono Y, Nakaya N, Suzuki Y, Koizumi Y, Tsuji I: Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer. 2004, 90 (7): 1361-1363. 10.1038/sj.bjc.6601652.
Hirvonen T, Mennen LI, de Bree A, Castetbon K, Galan P, Bertrais S, Arnault N, Hercberg S: Consumption of antioxidant-rich beverages and risk for breast cancer in French women. Ann Epidemiol. 2006, 16 (7): 503-508. 10.1016/j.annepidem.2005.09.011.
Ganmaa D, Willett WC, Li TY, Feskanich D, van Dam RM, Lopez-Garcia E, Hunter DJ, Holmes MD: Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer. 2008, 122 (9): 2071-2076. 10.1002/ijc.23336.
Bhoo Pathy N, Peeters P, van Gils C, Beulens JW, van der Graaf Y, Bueno-de-Mesquita B, Bulgiba A, Uiterwaal CS: Coffee and tea intake and risk of breast cancer. Breast Cancer Res Treat. 2009
Takezaki T, Inoue M, Kataoka H, Ikeda S, Yoshida M, Ohashi Y, Tajima K, Tominaga S: Diet and lung cancer risk from a 14-year population-based prospective study in Japan: with special reference to fish consumption. Nutr Cancer. 2003, 45 (2): 160-167. 10.1207/S15327914NC4502_04.
Mills PK, Beeson WL, Phillips RL, Fraser GE: Bladder cancer in a low risk population: results from the Adventist Health Study. Am J Epidemiol. 1991, 133 (3): 230-239.
Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Curhan GC, Willett WC, Giovannucci EL: Fluid intake and the risk of bladder cancer in men. N Engl J Med. 1999, 340 (18): 1390-1397. 10.1056/NEJM199905063401803.
Nagano J, Kono S, Preston DL, Moriwaki H, Sharp GB, Koyama K, Mabuchi K: Bladder-cancer incidence in relation to vegetable and fruit consumption: a prospective study of atomic-bomb survivors. Int J Cancer. 2000, 86 (1): 132-138. 10.1002/(SICI)1097-0215(20000401)86:1<132::AID-IJC21>3.0.CO;2-M.
Zeegers MP, Dorant E, Goldbohm RA, van den Brandt PA: Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study. Cancer Causes Control. 2001, 12 (3): 231-238. 10.1023/A:1011245627593.
Tripathi A, Folsom AR, Anderson KE: Iowa Women's Health Study. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer. 2002, 95 (11): 2316-2323. 10.1002/cncr.10975.
Hiatt RA, Klatsky AL, Armstrong MA: Pancreatic cancer, blood glucose and beverage consumption. Int J Cancer. 1988, 41 (6): 794-797. 10.1002/ijc.2910410603.
Zheng W, McLaughlin JK, Gridley G, Bjelke E, Schuman LM, Silverman DT, Wacholder S, Co-Chien HT, Blot WJ, Fraumeni JF: A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control. 1993, 4 (5): 477-482. 10.1007/BF00050867.
Shibata A, Mack TM, Paganini-Hill A, Ross RK, Henderson BE: A prospective study of pancreatic cancer in the elderly. Int J Cancer. 1994, 58 (1): 46-49. 10.1002/ijc.2910580109.
Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS: Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev. 2001, 10 (5): 429-437.
Isaksson B, Jonsson F, Pedersen NL, Larsson J, Feychting M, Permert J: Lifestyle factors and pancreatic cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer. 2002, 98 (3): 480-482. 10.1002/ijc.10256.
Lin Y, Tamakoshi A, Kawamura T, Inaba Y, Kikuchi S, Motohashi Y, Kurosawa M, Ohno Y: Risk of pancreatic cancer in relation to alcohol drinking, coffee consumption and medical history: findings from the Japan collaborative cohort study for evaluation of cancer risk. Int J Cancer. 2002, 99 (5): 742-746. 10.1002/ijc.10402.
Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D: Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol. 2002, 155 (9): 783-792. 10.1093/aje/155.9.783.
Luo J, Inoue M, Iwasaki M, Sasazuki S, Otani T, Ye W, Tsugane S, JPHC Study Group: Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur J Cancer Prev. 2007, 16 (6): 542-548. 10.1097/CEJ.0b013e32809b4d30.
Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, Wacholder S, Chien HT, Blot WJ: Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res. 1990, 50 (21): 6836-6840.
Ellison LF: Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study. Eur J Cancer Prev. 2000, 9 (2): 125-130. 10.1097/00008469-200004000-00009.
Washio M, Mori M, Sakauchi F, Watanabe Y, Ozasa K, Hayashi K, Miki T, Nakao M, Mikami K, Ito Y, Wakai K, Tamakoshi A, JACC Study Group: Risk factors for kidney cancer in a Japanese population: findings from the JACC Study. J Epidemiol. 2005, 15 (Suppl 2): S203-211. 10.2188/jea.15.S203.
Lee JE, Giovannucci E, Smith-Warner SA, Spiegelman D, Willett WC, Curhan GC: Total fluid intake and use of individual beverages and risk of renal cell cancer in two large cohorts. Cancer Epidemiol Biomarkers Prev. 2006, 15 (6): 1204-1211. 10.1158/1055-9965.EPI-05-0889.
Abel EL, Hendrix SO, McNeeley SG, Johnson KC, Rosenberg CA, Mossavar-Rahmani Y, Vitolins M, Kruger M: Daily coffee consumption and prevalence of nonmelanoma skin cancer in Caucasian women. Eur J Cancer Prev. 2007, 16 (5): 446-452. 10.1097/01.cej.0000243850.59362.73.
Veierød MB, Thelle DS, Laake P: Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer. 1997, 71 (4): 600-604.
Ma X, Park Y, Mayne ST, Wang R, Sinha R, Hollenbeck AR, Schatzkin A, Cross AJ: Diet, lifestyle, and acute myeloid leukemia in the NIH-AARP cohort. Am J Epidemiol. 2010, 171: 312-322. 10.1093/aje/kwp371.
Snowdon DA, Phillips RL: Coffee consumption and risk of fatal cancers. Am J Public Health. 1984, 74 (8): 820-823. 10.2105/AJPH.74.8.820.
Jacobsen BK, Bjelke E, Kvåle G, Heuch I: Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst. 1986, 76 (5): 823-831.
Nomura A, Heilbrun LK, Stemmermann GN: Prospective study of coffee consumption and the risk of cancer. J Natl Cancer Inst. 1986, 76 (4): 587-590.
Stensvold I, Jacobsen BK: Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control. 1994, 5 (5): 401-408. 10.1007/BF01694753.
Khan M, Goto R, Kobayashi K, Suzumura S, Nagata Y, Sonoda T, Sakauchi F, Washio M, Mori M: Dietary habits and cancer mortality among middle aged and older japanese living in hokkaido, japan by cancer site and sex. Asian Pacific J Cancer Prev. 2004, 5: 58-65.
Naganuma T, Kuriyama S, Kakizaki M, Sone T, Nakaya N, Ohmori-Matsuda K, Nishino Y, Fukao A, Tsuji I: Coffee consumption and the risk of oral, pharyngeal, and esophageal cancers in Japan: the Miyagi Cohort Study. Am J Epidemiol. 2008, 168 (12): 1425-1432. 10.1093/aje/kwn282.
Zheng W, Doyle TJ, Kushi LH, Sellers TA, Hong CP, Folsom AR: Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol. 1996, 144 (2): 175-182.
Lee JE, Hunter DJ, Spiegelman D, Adami HO, Bernstein L, van den Brandt PA, Buring JE, Cho E, English D, Folsom AR, Freudenheim JL, Gile GG, Giovannucci E, Horn-Ross PL, Leitzmann M, Marshall JR, Männistö S, McCullough ML, Miller AB, Parker AS, Pietinen P, Rodriguez C, Rohan TE, Schatzkin A, Schouten LJ, Willett WC, Wolk A, Zhang SM, Smith-Warner SA: Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies. Int J Cancer. 2007, 121 (10): 2246-2253. 10.1002/ijc.22909.
Arnlöv J, Vessby B, Risérus U: Coffee consumption and insulin sensitivity. JAMA. 2004, 291 (10): 1199-1201.
Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B: Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol. 2002, 40: 1155-1163. 10.1016/S0278-6915(02)00029-7.
Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Simioni C, Leung E, Maclennan S, Baraldi PG, Borea PA: Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol. 2007, 72 (2): 395-406. 10.1124/mol.106.032920.
Je Y, Liu W, Giovannucci E: Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer. 2009, 124 (7): 1662-1668. 10.1002/ijc.24124.
Vatten LJ, Solvoll K, Løken EB: Coffee consumption and the risk of breast cancer. A prospective study of 14,593 Norwegian women. Br J Cancer. 1990, 62 (2): 267-270. 10.1038/bjc.1990.274.
Nagata C, Kabuto M, Shimizu H: Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr Cancer. 1998, 30: 21-24. 10.1080/01635589809514635.
Jernstrom H, Klug TL, Sepkovic DW, Bradlow HL, Narod SA: Predictors of the plasma ratio of 2-hydroxyestrone to 16-alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups. Carcinogenesis. 2003, 24: 991-1005. 10.1093/carcin/bgg047.
Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, Negri E, Franceschi S, La Vecchia C: Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology. 2007, 46 (2): 430-435. 10.1002/hep.21708.
Larsson SC, Wolk A: Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology. 2007, 132 (5): 1740-1745. 10.1053/j.gastro.2007.03.044.
Tanaka T, Nishikawa A, Shima H, Sugie S, Shinoda T, Yoshimi N, Iwata H, Mori H: Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci. 1990, 52: 429-440.
He P, Noda Y, Sugiyama K: Suppressive effect of coffee on lipopolysaccharide-induced hepatitis in D-galactosamine-sensitized rats. Biosci Biotechnol Biochem. 2001, 65: 1924-1927. 10.1271/bbb.65.1924.
Ruhl CE, Everhart JE: Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2005, 128: 24-32. 10.1053/j.gastro.2004.09.075.
La Vecchia C, Negri E, Cavalieri d'Oro L, Franceschi S: Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev. 1998, 7: 315-320. 10.1097/00008469-199808000-00007.
Zeegers MP, Tan FE, Goldbohm RA, van den Brandt PA: Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis. Int J Epidemiol. 2001, 30 (2): 353-362. 10.1093/ije/30.2.353.
Bracken MB, Triche E, Grosso L, Hellenbrand K, Belanger K, Leaderer BP: Heterogeneity in assessing self-reports of caffeine exposure: implications for studies of health effects. Epidemiology. 2002, 13: 165-171. 10.1097/00001648-200203000-00011.